EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 685-693

  Feng, Wenjing ^a   Xu, Xizhen ^a   Zhao, Gang ^b   Li, Geng ^a   Liu, Tiantian ^a   Zhao, Junjie ^a   Dong, Ruolan ^a   Wang, Dao Wen ^a   Tu, Ling ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cytochrome P450 2J2; Epoxyeicosatrienoic acids; Migration; Proliferation

Indexed keywords

CYTOCHROME P450 2J2; EPOXYICOSATRIENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE OVEREXPRESSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL MOVEMENT; CELL SURVIVAL; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; KI-67 ANTIGEN; MAP KINASE SIGNALING SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY ARTERY; SWINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880399318     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1435     Document Type: Article

References (42)

1. Stefanec T: Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 117: 841-854, 2000.
2. Yang X, Long L, Reynolds PN and Morrell NW: Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells. Pulm Circ 1: 103-110, 2011.
3. Wort SJ, Ito M, Chou PC, et al: Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-kappaB binding and histone acetylation at specific kappaB sites. J Biol Chem 284: 24297-24305, 2009.
4. Soon E, Holmes AM, Treacy CM, et al: Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122: 920-927, 2010.
5. Antonelli-Orlidge A, Saunders KB, Smith SR and D'Amore PA: An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86: 4544-4548, 1989.
6. Sakao S, Taraseviciene-Stewart L, Wood K, Cool CD and Voelkel NF: Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 291: L362-L368, 2006.
7. Sturrock A, Cahill B, Norman K, et al: Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290: L661-L673, 2006.
8. Ma W, Han W, Greer PA, et al: Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. J Clin Invest 121: 4548-4566, 2011.
9. Wu S, Moomaw CR, Tomer KB, Falck JR and Zeldin DC: Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271: 3460-3468, 1996.
10. Zeldin DC: Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-36062, 2001.
11. Node K, Huo Y, Ruan X, et al: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279, 1999.
12. Pasceri V, Wu HD, Willerson JT and Yeh ET: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101: 235-238, 2000.
13. Wang N, Verna L, Chen NG, et al: Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 277: 34176-34181, 2002.
14. Feige JN, Gelman L, Michalik L, Desvergne B and Wahli W: From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 45: 120-159, 2006.
15. Sacerdoti D, Colombrita C, Di Pascoli M, et al: 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells. Prostaglandins Other Lipid Mediat 82: 155-161, 2007.
16. Wang H, Lin L, Jiang J, et al: Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther 307: 753-764, 2003.
17. Wang Y, Wei X, Xiao X, et al: Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 314: 522-532, 2005.
18. Yang S, Lin L, Chen JX, et al: Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways. Am J Physiol Heart Circ Physiol 293: H142-H151, 2007.
19. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS and Liao JK: Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res 90: 1020-1027, 2002.
20. Zheng C, Wang L, Li R, et al: Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. Am J Respir Cell Mol Biol 43: 740-749, 2010.
21. Tian X, Vroom C, Ghofrani HA, et al: Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling. PLoS One 6: e18136, 2011.
22. Dhanasekaran A, Al-Saghir R, Lopez B, et al: Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature. Am J Physiol Heart Circ Physiol 291: H517-H531, 2006.
23. Yang B, Graham L, Dikalov S, et al: Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60: 310-320, 2001.
24. Yuan P, Salvadore G, Li X, et al: Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life? Bipolar Disord 11: 256-269, 2009.
25. Kim HY, Hwang JY, Kim SW, et al: The CXCR4 antagonist AMD3100 has dual effects on survival and proliferation of myeloma cells in vitro. Cancer Res Treat 42: 225-234, 2010.
26. Clark PE, Polosukhina DA, Gyabaah K, Moses HL, Thorburn A and Zent R: TRAIL and interferon-alpha act synergistically to induce renal cell carcinoma apoptosis. J Urol 184: 1166-1174, 2010.
27. Zhang M, He Z, Wen L, et al: Cadmium suppresses the proliferation of piglet Sertoli cells and causes their DNA damage, cell apoptosis and aberrant ultrastructure. Reprod Biol Endocrinol 8: 97, 2010.
28. He J and Bazan HE: Epidermal growth factor synergism with TGF-beta1 via PI-3 kinase activity in corneal keratocyte differentiation. Invest Ophthalmol Vis Sci 49: 2936-2945, 2008.
29. Merlo S, Frasca G, Canonico PL and Sortino MA: Differential involvement of estrogen receptor alpha and estrogen receptor beta in the healing promoting effect of estrogen in human keratinocytes. J Endocrinol 200: 189-197, 2009.
30. Xu C, Gui Q, Chen W, et al: Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 30: 63, 2011.
31. Cool CD, Stewart JS, Werahera P, et al: Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 155: 411-419, 1999.
32. Yi ES, Kim H, Ahn H, et al: Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med 162: 1577-1586, 2000.
33. Wang Q, Zuo XR, Wang YY, Xie WP, Wang H and Zhang M: Monocrotaline- induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats. Vascul Pharmacol 58: 71-77, 2013.
34. Fujita M, Shannon JM, Irvin CG, et al: Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 280: L39-L49, 2001.
35. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q and Stewart DJ: Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96: 442-450, 2005.
36. Sage E, Mercier O, Van den Eyden F, et al: Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery. Respir Res 9: 19, 2008.
37. Taraseviciene-Stewart L, Kasahara Y, Alger L, et al: Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15: 427-438, 2001.
38. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, et al: Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 98: 209-217, 2006.
39. Sun CK, Lee FY, Sheu JJ, et al: Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats. J Pharmacol Exp Ther 330: 718-726, 2009.
40. Liu Y, Ma C, Zhang Q, et al: The key role of transforming growth factor-beta receptor I and 15-lipoxygenase in hypoxia-induced proliferation of pulmonary artery smooth muscle cells. Int J Biochem Cell Biol 44: 1184-1202, 2012.
41. Ismail S, Sturrock A, Wu P, et al: NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol 296: L489-L499, 2009.
42. Revermann M, Barbosa-Sicard E, Dony E, et al: Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. J Hypertens 27: 322-331, 2009.